SC
AXNX

Samlyn Capital’s Axonics, Inc. Common Stock AXNX Stock Holding History

Samlyn Capital’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-236,941
Closed -$15.4M – 179
2021
Q3 		$15.4M Sell
236,941
-136,587
-37% -$9.32M 0.21% 89
2021
Q2 		$23.7M Sell
373,528
-95,286
-20% -$5.62M 0.35% 65
2021
Q1 		$28.1M Sell
468,814
-176,915
-27% -$9.62M 0.39% 61
2020
Q4 		$32.2M Buy
645,729
+50,954
+9% +$2.39M 0.46% 67
2020
Q3 		$30.4M Sell
594,775
-304,507
-34% -$12.7M 0.55% 59
2020
Q2 		$31.6M Buy
899,282
+221,892
+33% +$7.64M 0.58% 54
2020
Q1 		$17.2M Buy
677,390
+159,356
+31% +$4.74M 0.43% 56
2019
Q4 		$14.4M Buy
+518,034
New +$12.4M 0.3% 71

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Samlyn Capital's AXNX Position: Q4 2021 in Review

Samlyn Capital sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2021, closing a stake of 236,941 shares — an estimated $15.4M sold.

Samlyn Capital first reported a position in AXNX in Q4 2019 and held it in 8 quarters. The position peaked at $32.2M in Q4 2020. 180 funds tracked by Wall St. Rank hold AXNX as of Q4 2021.

  • Samlyn Capital reported no remaining Axonics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Samlyn Capital sold 236,941 Axonics, Inc. Common Stock shares in Q4 2021, an estimated $15.4M.
  • Samlyn Capital first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 8 quarters.
  • Samlyn Capital's Axonics, Inc. Common Stock position peaked at $32.2M in Q4 2020.
  • 180 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2021.

Based on Samlyn Capital's 13F filing for Q4 2021, filed 14 Feb 2022.